Order Article Reprints

Bocsik A, Gróf I, Kiss L, Ötvös F, Zsíros O, Daruka L, Fülöp L, Vastag M, Kittel Á, Imre N, et al. Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability. Pharmaceutics. 2019; 11(2):73. https://doi.org/10.3390/pharmaceutics11020073

Bocsik, Alexandra, Ilona Gróf, Lóránd Kiss, Ferenc Ötvös, Ottó Zsíros, Lejla Daruka, Lívia Fülöp, Monika Vastag, Ágnes Kittel, Norbert Imre, and et al. 2019. "Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability" Pharmaceutics 11, no. 2: 73. https://doi.org/10.3390/pharmaceutics11020073

Bocsik, A., Gróf, I., Kiss, L., Ötvös, F., Zsíros, O., Daruka, L., Fülöp, L., Vastag, M., Kittel, Á., Imre, N., Martinek, T. A., Pál, C., Szabó-Révész, P., & Deli, M. A. (2019). Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability. Pharmaceutics, 11(2), 73. https://doi.org/10.3390/pharmaceutics11020073